Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H.

Ann Neurol. 2009 Nov;66(5):630-43. doi: 10.1002/ana.21837.

PMID:
19937948
3.

Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.

Niino M, Uesugi H, Takahashi T, Fukazawa T, Minami N, Tashiro J, Fujiki N, Doi S, Kikuchi S.

Intern Med. 2012;51(7):809-12. Epub 2012 Apr 1.

4.

Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter.

Yoshimine S, Sakai T, Ogasawara M, Shikishima K, Tsuneoka H, Tanaka K.

Jpn J Ophthalmol. 2011 Nov;55(6):647-50. doi: 10.1007/s10384-011-0086-3. Epub 2011 Sep 9.

PMID:
21909659
5.

Neuromyelitis optica: diagnosis, pathogenesis, and treatment.

Cree B.

Curr Neurol Neurosci Rep. 2008 Sep;8(5):427-33. Review.

PMID:
18713580
6.

Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?

Bradl M, Lassmann DH.

Int MS J. 2008 Sep;15(3):75-8. Review.

PMID:
18812056
7.

Neuromyelitis optica with HTLV-1 infection: different from acute progressive HAM?

Koga M, Takahashi T, Kawai M, Negoro K, Kanda T.

Intern Med. 2009;48(13):1157-9. Epub 2009 Jul 1.

8.

Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis.

Franciotta D, Zardini E, Caporali R, Piccolo L, Alberici E, Romani A, Bergamaschi R, Marchioni E, Ceroni M, Piccolo G.

J Neurol Sci. 2011 Apr 15;303(1-2):139-41. doi: 10.1016/j.jns.2011.01.011. Epub 2011 Feb 5.

PMID:
21296362
9.

Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature.

Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B.

Clin Neurol Neurosurg. 2012 May;114(4):331-5. doi: 10.1016/j.clineuro.2011.10.048. Epub 2011 Dec 3.

PMID:
22138095
10.

Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.

Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H, Masaki K, Yoshiura T, Yamasaki R, Ohyagi Y, Kira J.

J Neurol Sci. 2010 Apr 15;291(1-2):37-43. doi: 10.1016/j.jns.2010.01.009. Epub 2010 Feb 1.

PMID:
20122699
11.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.

Brain. 2007 May;130(Pt 5):1235-43. Epub 2007 Apr 19.

12.

Aquaporin-4 autoantibodies in a paraneoplastic context.

Pittock SJ, Lennon VA.

Arch Neurol. 2008 May;65(5):629-32. doi: 10.1001/archneur.65.5.629. Erratum in: Arch Neurol. 2008 Oct;65(10):1394.

PMID:
18474738
13.

Recurrent spinal cord attacks in a patient with a limited form of neuromyelitis optica.

Matsumoto H, Shimizu T, Okabe S, Konoma Y, Takahashi T, Hirakawa-Yamada M, Igeta Y, Hashida H.

Intern Med. 2011;50(5):509-13. Epub 2011 Mar 1.

14.

"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.

Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S.

Ann Neurol. 2009 Sep;66(3):425-8. doi: 10.1002/ana.21753.

PMID:
19798642
15.

Influenza-associated monophasic neuromyelitis optica.

Nakamura Y, Ikeda K, Yoshii Y, Ito H, Hirayama T, Kawabe K, Kano O, Iwasaki Y.

Intern Med. 2011;50(15):1605-9. Epub 2011 Aug 1.

16.

Atypical presentations of neuromyelitis optica.

Sato D, Fujihara K.

Arq Neuropsiquiatr. 2011 Oct;69(5):824-8. Review. Erratum in: Arq Neuropsiquiatr. 2012 Jan;70(1): doi.org/10.1590/S0004-282X2012000100023.

17.

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Ishii N, Itoyama Y.

Tohoku J Exp Med. 2006 Dec;210(4):307-13.

18.

Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica.

Saiki S, Ueno Y, Moritani T, Sato T, Sekine T, Kawajiri S, Adachi S, Yokoyama K, Tomizawa Y, Motoi Y, Hattori N.

J Neurol Sci. 2009 Sep 15;284(1-2):217-9. doi: 10.1016/j.jns.2009.05.022. Epub 2009 Jun 3.

PMID:
19497587
19.

[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].

Misu T, Fujihara K, Itoyama Y.

Brain Nerve. 2008 May;60(5):527-37. Review. Japanese.

PMID:
18516975
20.

Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.

Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.

Semin Ophthalmol. 2008 May-Jun;23(3):191-200. doi: 10.1080/08820530802049921.

PMID:
18432545
Items per page

Supplemental Content

Write to the Help Desk